Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment and Prediction of the Effectiveness of Mepolizumab Anti-IL-5/IL5R Inhibitors in a Real-world Setting

NCT06239441 is registered in ClinicalTrials.gov with Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal as lead sponsor.

NCT NCT06239441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06239441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment and Prediction of the Effectiveness of Mepolizumab Anti-IL-5/IL5R Inhibitors in a Real-world Setting
Lead sponsor
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Phase
Observational
Overall status
Completed
Start date
February 16, 2021
Completion date
November 29, 2023
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma